Mid-term outcomes of tricuspid annuloplasty using the Tri-Ad Adams tricuspid annuloplasty ring
Interdisciplinary CardioVascular and Thoracic Surgery · 03.07.2024 · 39 (1)
DOI: 10.1093/icvts/ivae131 ↗Kurz gefasst
Fachartikel in der Zeitschrift Interdisciplinary CardioVascular and Thoracic Surgery, online erschienen am 12.07.2024. Verfasst von Heemoon Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic and Cardiovascular Surgery, Bucheon Sejong Hospital, Bucheon, Gyeonggi-do, Republic of Korea. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
OBJECTIVES The Tri-Ad Adams tricuspid annuloplasty ring is a recent innovative prosthesis characterized by a semi-rigid central component and fully flexible extremities. The goal of this study was to assess the short-term and mid-term results following implantation of the Tri-Ad Adams ring. METHODS A retrospective analysis was conducted on patients who underwent tricuspid annuloplasty using the Tri-Ad Adams ring between August 2016 and October 2021. RESULTS Our study enrolled a total of 248 participants. The median age was 64.0 (interquartile range: 56.0–71.5) years. The median EuroSCORE II was 4.3% (2.7–7.5%), with 37 patients (14.9%) having a history of cardiac operations. Tricuspid regurgitation of grade 2–3 was observed in 63.7% of cases, and the median tricuspid annular diameter was 3.3 (2.8–3.6) cm. Concurrent procedures included mitral valve replacement (n = 160, 64.5%), mitral valve repair (n = 75, 30.2%), aortic valve replacement (n = 72, 29.0%) and the maze procedure (n = 170, 68.5%). Immediate postoperative tricuspid regurgitation≥moderate was present in 1 patient (0.4%). Early death occurred in 14 patients (5.6%). Major complications included low cardiac output syndrome (n = 18, 0.3%), acute kidney injury (n = 14, 5.6%) and permanent pacemaker placement (n = 15, 6.0%). According to the Kaplan–Meier analysis, the 4-year rates of freedom from overall mortality and moderate-to-severe tricuspid regurgitation were 96.9% and 91.6%, respectively. There were no incidents of tricuspid valve reoperations, ring detachment or significant tricuspid stenosis (trans-tricuspid valve gradient ≥ 5 mmHg). CONCLUSIONS Tricuspid annuloplasty utilizing the Tri-Ad Adams ring demonstrated favourable outcomes in both the early and midterm periods. Further studies are warranted to confirm the long-term results.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic and Cardiovascular Surgery, Bucheon Sejong Hospital, Bucheon, Gyeonggi-do, Republic of Korea.
- Department of Thoracic and Cardiovascular Surgery, Kangnam Sacred Heart Hospital, Hallym University Medical Center, Hallym University College of Medicine, Seoul, Republic of Korea.
- Division of Cardiology, Department of Internal Medicine, Bucheon Sejong Hospital, Bucheon, Gyeonggi-do, Republic of Korea.
ORCID-Profile: Heemoon Lee, Jae Suk Yoo
Zitieren
APA
Lee, H., Kim, J., Jung, J. H., & Yoo, J. S. (2024). Mid-term outcomes of tricuspid annuloplasty using the Tri-Ad Adams tricuspid annuloplasty ring. Interdisciplinary CardioVascular and Thoracic Surgery, 39(1). https://doi.org/10.1093/icvts/ivae131
Vancouver
Lee H, Kim J, Jung JH, Yoo JS. Mid-term outcomes of tricuspid annuloplasty using the Tri-Ad Adams tricuspid annuloplasty ring. Interdisciplinary CardioVascular and Thoracic Surgery. 2024;39(1). doi:10.1093/icvts/ivae131
BibTeX
@article{Lee2024,
author = {Lee, Heemoon and Kim, Jihoon and Jung, Ji-Hyun and Yoo, Jae Suk},
title = {Mid-term outcomes of tricuspid annuloplasty using the Tri-Ad Adams tricuspid annuloplasty ring},
journal = {Interdisciplinary CardioVascular and Thoracic Surgery},
year = {2024},
volume = {39},
number = {1},
doi = {10.1093/icvts/ivae131}
}
EUVIMED